Related Experiment Video
Updated: Jun 29, 2025

Assessment of Glutamine as a Fuel Source for Alveolar Macrophages Exposed to Chronic Ethanol Using an Extracellular Flux Bioanalyzer
Published on: November 15, 2024
Pneumocystis Pneumonia in a Patient With Alcoholic Hepatitis
Emily Krier1, Ursulina Tomczak1, Thomas Checketts2
1Creighton University School of Medicine, Omaha, NE.
Abstract:
Pneumocystis jirovecii is an opportunistic fungus typically causing pulmonary infection in immunocompromised persons. We present a case of Pneumocystis jirovecii pneumonia (PJP) in a patient with alcoholic hepatitis and underlying cirrhosis. PJP in patients with alcoholic hepatitis or cirrhosis is sparsely reported in literature. This condition carries a poor prognosis and high mortality. Clinicians need to recognize alcohol use resulting in liver damage as a significant etiological risk factor for PJP.
Insights
Pneumocystis jirovecii pneumonia (PJP) is rare in patients with alcoholic hepatitis and cirrhosis. Early recognition of alcohol-related liver damage as a risk factor is crucial for managing this severe lung infection.
Area of Science:
- Medical Mycology
- Hepatology
- Pulmonology
Background:
- Pneumocystis jirovecii pneumonia (PJP) commonly affects immunocompromised individuals.
- Alcoholic hepatitis and cirrhosis are significant risk factors for opportunistic infections.
- Literature on PJP in patients with alcoholic liver disease is sparse.
Observation:
- A case of PJP was diagnosed in a patient with alcoholic hepatitis and underlying cirrhosis.
- The patient presented with pulmonary symptoms indicative of PJP.
Findings:
- PJP in the context of alcoholic hepatitis and cirrhosis is associated with a poor prognosis.
- This specific patient demographic exhibits a high mortality rate.
- Alcohol use leading to liver damage is identified as a critical etiological factor for PJP.
Implications:
- Clinicians should consider PJP in patients with a history of alcohol use and liver damage.
- Prompt diagnosis and management of PJP are essential in this vulnerable population.
- Increased awareness of this association may improve patient outcomes and reduce mortality.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pneumonia III: Complications and Assessment
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...

